Sheng‐Di Chen

516 total citations
13 papers, 334 citations indexed

About

Sheng‐Di Chen is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Sheng‐Di Chen has authored 13 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Molecular Biology. Recurrent topics in Sheng‐Di Chen's work include Parkinson's Disease Mechanisms and Treatments (5 papers), Nuclear Receptors and Signaling (3 papers) and Alzheimer's disease research and treatments (2 papers). Sheng‐Di Chen is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (5 papers), Nuclear Receptors and Signaling (3 papers) and Alzheimer's disease research and treatments (2 papers). Sheng‐Di Chen collaborates with scholars based in China, United States and Palestinian Territory. Sheng‐Di Chen's co-authors include Gang Wang, Zhen Hong, Jing Pan, Zhikun Sun, Hongqi Yang, Yuyan Tan, Ying Wang, Jianqing Ding, Qin Xiao and Zhiquan Wang and has published in prestigious journals such as European Journal of Neuroscience, Movement Disorders and Alzheimer s & Dementia.

In The Last Decade

Sheng‐Di Chen

13 papers receiving 328 citations

Peers

Sheng‐Di Chen
Niyatee Samudra United States
M M Esiri United Kingdom
Dominique Twelves United Kingdom
Juliana Bronzova United States
Petros Takousis United Kingdom
Niyatee Samudra United States
Sheng‐Di Chen
Citations per year, relative to Sheng‐Di Chen Sheng‐Di Chen (= 1×) peers Niyatee Samudra

Countries citing papers authored by Sheng‐Di Chen

Since Specialization
Citations

This map shows the geographic impact of Sheng‐Di Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng‐Di Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng‐Di Chen more than expected).

Fields of papers citing papers by Sheng‐Di Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng‐Di Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng‐Di Chen. The network helps show where Sheng‐Di Chen may publish in the future.

Co-authorship network of co-authors of Sheng‐Di Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng‐Di Chen. A scholar is included among the top collaborators of Sheng‐Di Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng‐Di Chen. Sheng‐Di Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Ren, Ru‐Jing, Qiang Huang, Gang Xu, et al.. (2021). Association between Alzheimer's disease and risk of cancer: A retrospective cohort study in Shanghai, China. Alzheimer s & Dementia. 18(5). 924–933. 13 indexed citations
2.
Tian, Wotu, Lihua Liu, Haiyan Zhou, et al.. (2020). New phenotype of DCTN1‐related spectrum: early‐onset dHMN plus congenital foot deformity. Annals of Clinical and Translational Neurology. 7(2). 200–209. 6 indexed citations
3.
Tian, Wotu, Haiyan Zhou, Zeyu Zhu, et al.. (2019). Lysosomal degradation of GMPPB is associated with limb‐girdle muscular dystrophy type 2T. Annals of Clinical and Translational Neurology. 6(6). 1062–1071. 8 indexed citations
4.
Tian, Wotu, Xiao‐Jun Huang, Xiao Mao, et al.. (2018). Proline‐rich transmembrane protein 2negative paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 163 patients. Movement Disorders. 33(3). 459–467. 35 indexed citations
5.
Cui, Shishuang, Juanjuan Du, Pei Huang, et al.. (2017). Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients. Brain and Behavior. 7(6). e00712–e00712. 14 indexed citations
6.
Huang, Pei, Yuyan Tan, Dongqiang Liu, et al.. (2017). Motor‐symptom laterality affects acquisition in Parkinson's disease: A cognitive and functional magnetic resonance imaging study. Movement Disorders. 32(7). 1047–1055. 26 indexed citations
7.
Liu, Jun, Qin Xiao, Ying Wang, et al.. (2013). Analysis of genome‐wide association study‐linked loci in Parkinson's disease of Mainland China. Movement Disorders. 28(13). 1892–1895. 35 indexed citations
8.
Cao, Li, Ting Zhang, Huidong Tang, et al.. (2010). Four novel mutations in the GCH1 gene of Chinese patients with dopa‐responsive dystonia. Movement Disorders. 25(6). 755–760. 29 indexed citations
9.
Hong, Zhen, Jun Liu, Xia Li, et al.. (2009). Identification of glial‐cell‐line‐derived neurotrophic factor‐regulated proteins of striatum in mouse model of Parkinson disease. PROTEOMICS - CLINICAL APPLICATIONS. 3(9). 1072–1083. 3 indexed citations
10.
Sun, Zhikun, Hongqi Yang, Jing Pan, et al.. (2008). Protective effects of erythropoietin on tau phosphorylation induced by β‐amyloid. Journal of Neuroscience Research. 86(13). 3018–3027. 48 indexed citations
11.
Hong, Zhen, Gang Wang, Jing Gu, et al.. (2007). Tripchlorolide protects against MPTP‐induced neurotoxicity in C57BL/6 mice. European Journal of Neuroscience. 26(6). 1500–1508. 32 indexed citations
12.
Yang, Hongqi, Jing Pan, Maowen Ba, et al.. (2007). New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α‐secretase activity. European Journal of Neuroscience. 26(2). 381–391. 34 indexed citations
13.
Wang, Gang, Qi Cheng, Rui Zheng, et al.. (2006). Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China. Movement Disorders. 21(9). 1439–1443. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026